Femasys (FEMY) Interest Expenses (2020 - 2026)
Femasys' (FEMY) quarterly Interest Expenses came in at $9.0 million in Q1 2026, up 1853.31% YoY from $459449.0 in Q1 2025, and up 708.68% on a QoQ basis from -$1.5 million in Q4 2025.
Femasys (FEMY) Interest Expenses (2020 - 2026) Analysis & Trends
Femasys (FEMY) has 7 years of Interest Expenses data on file, last reported at $9.0 million in Q1 2026.
- Quarterly Interest Expenses rose 1853.31% year-over-year to $9.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.0 million (up 427.45% YoY) and the FY2025 annual result came in at $35.0 million, up 13.6% from the prior year.
- Interest Expenses rose to $9.0 million in Q1 2026, from -$1.5 million in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $9.0 million in Q1 2026 to a low of -$1.5 million in Q4 2025.
- A 5-year average of $649360.1 and a median of $94596.0 in 2022 frame the typical range for Interest Expenses.
- Annual changes were most pronounced in 2024 — Interest Expenses jumped 29339.8% — and 2025, when it slumped 434.77%.
- Tracing FEMY's Interest Expenses over 5 years: stood at $3842.0 in 2022, then fell by 22.25% to $2987.0 in 2023, then soared by 14644.63% to $440422.0 in 2024, then tumbled by 434.77% to -$1.5 million in 2025, then jumped by 708.68% to $9.0 million in 2026.
- The last three Interest Expenses figures came in at $9.0 million (Q1 2026), -$1.5 million (Q4 2025), and $619562.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 132.00 Mn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 53.00 Mn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | - |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 2.60 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 20.90 Mn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | - |
| 10 | Femasys | 8.98 Mn | 7.54 Mn | 189,391.00 | 186,050.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.97 Mn |
| Mar 31, 2026 | 8.97 Mn |
| Dec 31, 2025 | -1.47 Mn |
| Dec 31, 2025 | -1.47 Mn |
| Jun 30, 2025 | 619,562.00 |
| Jun 30, 2025 | 619,562.00 |
| Mar 31, 2025 | 459,449.00 |
| Mar 31, 2025 | 459,449.00 |
| Dec 31, 2024 | 440,422.00 |
| Dec 31, 2024 | 440,422.00 |
| Sep 30, 2024 | 413,290.00 |
| Sep 30, 2024 | 413,290.00 |
| Jun 30, 2024 | 388,311.00 |
| Jun 30, 2024 | 388,311.00 |
| Mar 31, 2024 | 361,552.00 |
| Mar 31, 2024 | 361,552.00 |
| Dec 31, 2023 | 2,987.00 |
| Dec 31, 2023 | 2,987.00 |
| Sep 30, 2023 | 7,447.00 |
| Sep 30, 2023 | 7,447.00 |